165 related articles for article (PubMed ID: 34896003)
21. In vitro modeling of experimental succinic semialdehyde dehydrogenase deficiency (SSADHD) using brain-derived neural stem cells.
Vogel KR; Ainslie GR; Jansen EE; Salomons GS; Roullet JB; Gibson KM
PLoS One; 2017; 12(10):e0186919. PubMed ID: 29053743
[TBL] [Abstract][Full Text] [Related]
22. ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations.
Afshar-Saber W; Teaney NA; Winden KD; Jumo H; Shi X; McGinty G; Hubbs J; Chen C; Tokatly Latzer I; Gasparoli F; Ebrahimi-Fakhari D; Buttermore ED; Roullet JB; Pearl PL; Sahin M
Neurobiol Dis; 2024 Jan; 190():106386. PubMed ID: 38110041
[TBL] [Abstract][Full Text] [Related]
23. Postmortem Analyses in a Patient With Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): II. Histological, Lipid, and Gene Expression Outcomes in Regional Brain Tissue.
Walters DC; Lawrence R; Kirby T; Ahrendsen JT; Anderson MP; Roullet JB; Murphy EJ; Gibson KM;
J Child Neurol; 2021 Nov; 36(13-14):1177-1188. PubMed ID: 33557678
[TBL] [Abstract][Full Text] [Related]
24. mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
Vogel KR; Ainslie GR; Gibson KM
J Inherit Metab Dis; 2016 Nov; 39(6):877-886. PubMed ID: 27518770
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of thirty-four suspected pathogenic missense variants in ALDH5A1 gene associated with succinic semialdehyde dehydrogenase deficiency.
Pop A; Smith DEC; Kirby T; Walters D; Gibson KM; Mahmoudi S; van Dooren SJM; Kanhai WA; Fernandez-Ojeda MR; Wever EJM; Koster J; Waterham HR; Grob B; Roos B; Wamelink MMC; Chen J; Natesan S; Salomons GS
Mol Genet Metab; 2020 Jul; 130(3):172-178. PubMed ID: 32402538
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.
Knerr I; Pearl PL; Bottiglieri T; Snead OC; Jakobs C; Gibson KM
J Inherit Metab Dis; 2007 Jun; 30(3):279-94. PubMed ID: 17457693
[TBL] [Abstract][Full Text] [Related]
27. The presence and severity of epilepsy coincide with reduced γ-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency.
Tokatly Latzer I; Bertoldi M; DiBacco ML; Arning E; Tsuboyama M; MacMullin P; Sachee D; Rotenberg A; Lee HHC; Aygun D; Opladen T; Jeltsch K; García-Cazorla À; Roullet JB; Gibson KM; Pearl PL
Epilepsia; 2023 Jun; 64(6):1516-1526. PubMed ID: 36961285
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation of ALDH5A1 gene associated with succinic semialdehyde dehydrogenase deficiency.
Lin CY; Weng WC; Lee WT
J Child Neurol; 2015 Mar; 30(4):486-9. PubMed ID: 25246302
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis and prenatal diagnosis in a Chinese family with succinic semialdehyde dehydrogenase and a systematic review of the literature of reported ALDH5A1 mutations.
Liu N; Kong XD; Kan QC; Shi HR; Wu QH; Zhuo ZH; Bai QL; Jiang M
J Perinat Med; 2016 May; 44(4):441-51. PubMed ID: 25431891
[TBL] [Abstract][Full Text] [Related]
30. Development of a Quality-of-Life Survey for Patients With Succinic Semialdehyde Dehydrogenase Deficiency, a Rare Disorder of GABA Metabolism.
Bose M; Roullet JB; Gibson KM; Rizzo WB; Mansur HM; McConnell A; Hoffman CA; DiBacco ML; Pearl PL
J Child Neurol; 2021 Nov; 36(13-14):1223-1230. PubMed ID: 34463169
[TBL] [Abstract][Full Text] [Related]
31. Establishment and validation of a clinical severity scoring system for succinic semialdehyde dehydrogenase deficiency.
Tokatly Latzer I; Roullet JB; Gibson KM; Pearl PL
J Inherit Metab Dis; 2023 Sep; 46(5):992-1003. PubMed ID: 37219411
[TBL] [Abstract][Full Text] [Related]
32. Novel biomarkers and age-related metabolite correlations in plasma and dried blood spots from patients with succinic semialdehyde dehydrogenase deficiency.
Kirby T; Walters DC; Shi X; Turgeon C; Rinaldo P; Arning E; Ashcraft P; Bottiglieri T; DiBacco M; Pearl PL; Roullet JB; Gibson KM
Orphanet J Rare Dis; 2020 Sep; 15(1):261. PubMed ID: 32967698
[TBL] [Abstract][Full Text] [Related]
33. Succinic semialdehyde dehydrogenase deficiency of four Chinese patients and prenatal diagnosis for three fetuses.
Li X; Ding Y; Liu Y; Zhang Y; Song J; Wang Q; Li M; Qin Y; Huang S; Yang Y
Gene; 2015 Dec; 574(1):41-7. PubMed ID: 26220405
[TBL] [Abstract][Full Text] [Related]
34. The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency.
Julia-Palacios NA; Kuseyri Hübschmann O; Olivella M; Pons R; Horvath G; Lücke T; Fung CW; Wong SN; Cortès-Saladelafont E; Rovira-Remisa MM; Yıldız Y; Mercimek-Andrews S; Assmann B; Stevanović G; Manti F; Brennenstuhl H; Jung-Klawitter S; Jeltsch K; Sivri HS; Garbade SF; García-Cazorla À; Opladen T
J Inherit Metab Dis; 2024 May; 47(3):447-462. PubMed ID: 38499966
[TBL] [Abstract][Full Text] [Related]
35. Transcranial Magnetic Stimulation in Succinic Semialdehyde Dehydrogenase Deficiency: A Measure of Maturational Trajectory of Cortical Excitability.
Tsuboyama M; Liu J; Kaye H; DiBacco M; Pearl PL; Rotenberg A
J Child Neurol; 2021 Nov; 36(13-14):1169-1176. PubMed ID: 34058900
[TBL] [Abstract][Full Text] [Related]
36. Succinic Semialdehyde Dehydrogenase Deficiency in a Chinese Boy: A Novel ALDH5A1 Mutation With Severe Phenotype.
Tay CG; Ariffin H; Yap S; Rahmat K; Sthaneshwar P; Ong LC
J Child Neurol; 2015 Jun; 30(7):927-31. PubMed ID: 25122112
[TBL] [Abstract][Full Text] [Related]
37. Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.
Vogel KR; Ainslie GR; McConnell A; Roullet JB; Gibson KM
Toxicol In Vitro; 2018 Feb; 46():203-212. PubMed ID: 29031482
[TBL] [Abstract][Full Text] [Related]
38. Targeted screening of succinic semialdehyde dehydrogenase deficiency (SSADHD) employing an enzymatic assay for γ-hydroxybutyric acid (GHB) in biofluids.
Wernli C; Finochiaro S; Volken C; Andresen-Streichert H; Buettler A; Gygax D; Salomons GS; Jansen EE; Ainslie GR; Vogel KR; Gibson KM
Mol Genet Metab Rep; 2017 Jun; 11():81-89. PubMed ID: 28649510
[TBL] [Abstract][Full Text] [Related]
39. Bi-allelic Mutations in ALDH5A1 is associated with succinic semialdehyde dehydrogenase deficiency and severe intellectual disability.
Fattahi M; Bushehri A; Alavi A; Asghariazar V; Nozari A; Ghasemi Firouzabadi S; Motamedian Dehkordi P; Javid M; Farajzadeh Valiliou S; Karimian J; Behjati F
Gene; 2020 Jul; ():144918. PubMed ID: 32621952
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency (Aldh5a1-/- mice).
Sauer SW; Kölker S; Hoffmann GF; Ten Brink HJ; Jakobs C; Gibson KM; Okun JG
Neurochem Int; 2007 Mar; 50(4):653-9. PubMed ID: 17303287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
